Crossmark

Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: a case report

Crossref DOI link: https://doi.org/10.1186/s12885-019-5352-7

Published Online: 2019-02-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Junhui

Chen, Jianxin https://orcid.org/0000-0002-0831-5934
License Information

Text and Data Mining valid from 2019-02-08
More Information

Article History

Received: 30 May 2018

Accepted: 5 February 2019

First Online: 8 February 2019

Ethics approval and consent to participate

: Not applicable.

: Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.